Navigation Links
Senior Executives of Cytyc Corporation, and Constitution Medical, Inc., Announce the Launch of ATON PARTNERS
Date:9/23/2013

BOSTON, Sept. 23, 2013 /PRNewswire/ -- Patrick Sullivan and Daniel Levangie, senior executives who led the emergence of Cytyc Corporation as a leading women's healthcare company and subsequently the formation of Constitution Medical, Inc., today announced the formation of ATON Partners, LLC.  Mr. Sullivan and Mr. Levangie formed ATON Partners to provide management advisory services to early stage medical device and in vitro diagnostic companies while evaluating investment opportunities within these areas of medical technology and product development.  Mr. Sullivan, former President and Chief Executive Officer of Cytyc Corporation, and Mr. Levangie, former Executive Vice President of Cytyc Corporation and President of Cytyc's Surgical Products Division, formed Constitution Medical Investors in Partnership with Warburg Pincus Private Equity in 2008 and subsequently built Constitution Medical, Inc.  Constitution Medical, Inc., developers of the Bloodhound Integrated Hematology System, was acquired by Roche Diagnostics in July 2013.

ATON Partners will provide advisory services to medical device and in vitro diagnostic companies where the principals will be able to leverage their product development, regulatory, clinical and commercial experience.  Over the course of 15 years at Cytyc, one of the leading companies focused on improving healthcare for women, Sullivan and Levangie led the executive team that grew Cytyc Corporation to approximately $700 million in annual revenues while establishing operations in 20 countries.

"Both Dan and I feel fortunate to have been able to lead the team that built Cytyc Corporation to its preeminent position in women's health, and more recently to have again led the talented CMI team as it developed the Bloodhound Integrated Hematology System.  With the integration of CMI with Roche Diagnostics now complete, we are excited to put our extensive experience to work in a new venture," said Mr. Sullivan.  "We are proud of our track record of success in creating value in the healthcare marketplace, and are looking forward to working with other talented management teams to provide guidance based upon our combined 50 years of experience in building great companies and significant shareholder value."

About ATON Partners, LLC
ATON Partners, LLC is a Boston-based private management advisory and investment firm focused on healthcare sector-related companies and technologies, led by Patrick Sullivan, formerly President and Chief Executive Officer of Cytyc Corporation and and Daniel Levangie, formerly Executive Vice President of Cytyc Corporation and President of Cytyc's Surgical Products Division.  ATON Partners focuses exclusively on companies involved in the development and commercialization of medical devices and in vitro diagnostics as well as investments in innovative, healthcare-related platform technologies and companies where the principals will be able to leverage their product development, regulatory, clinical and commercial experience.  For more information, visit www.ATONPartners.com  ATON Partners, LLC is located at 75 Arlington Street, Suite 500, Boston, MA 02116.


'/>"/>
SOURCE ATON Partners
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Trevena Appoints Roberto Cuca as Senior Vice President & Chief Financial Officer
2. New Research Finds Many Seniors Wrongly Think Public Health Insurance Exchanges Are Replacing Medicare Plans
3. Cyberonics Names Rohan J. Hoare, Ph.D. Senior Vice President, Strategic Planning
4. PRA Holdings Announces Proposed Private Offering of $375 Million Senior Notes Due 2023
5. Regeneron Announces Appointment of Robert E. Landry as Senior Vice President, Finance and Chief Financial Officer
6. GeNO LLC Announces Senior Management Appointment
7. MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
8. TeraRecon Appoints Jeff Sorenson as Senior Vice President Sales and Marketing
9. Former Pfizer/Wyeth Global Infectious Disease Pharmaceutical Executive, Lewis Barrett, Appointed Senior Vice President, Commercial Strategy of Synthetic Biologics, Inc.
10. Actavis Announces New Senior Unsecured Term Loan Credit and Guaranty Agreement
11. Astellas Appoints New Senior Vice President of Global Oncology Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
Breaking Medicine News(10 mins):